期刊论文详细信息
BMC Microbiology
Biotechnical paving of recombinant enterocin A as the candidate of anti-Listeria agent
Jianhua Wang1  Jianzhong Huang2  Di Xi1  Xiumin Wang1  Da Teng1  Yong Zhang1  Ruoyu Mao1  Xiaoyuan Hu2 
[1] Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, 12 Zhongguancun Nandajie St., Haidian District, Beijing 100081, P. R. China;College of Life Science, Engineering Research Center of Industrial Microbiology, Fujian Normal University, Fuzhou 350108, China
关键词: Expression;    Pichia pastoris;    Antimicrobial activity;    Listeria ivanovii;    Enterocin A;   
Others  :  1140474
DOI  :  10.1186/s12866-014-0220-8
 received in 2014-03-04, accepted in 2014-08-12,  发布年份 2014
PDF
【 摘 要 】

Background

Enterocin A is a classic IIa bacteriocin isolated firstly from Enterococcus faecium CTC492 with selective antimicrobial activity against Listeria strains. However, the application of enterocin A as an anti-Listeria agent has been limited due to its very low native yield. The present work describes high production of enterocin A through codon optimization strategy and its character study.

Results

The gene sequence of enterocin A was optimized based on preferential codon usage in Pichia pastoris to increase its expression efficiency. The highest anti-Listeria activity reached 51,200 AU/ml from 180 mg/l of total protein after 24 h of induction in a 5-L fermenter. Recombinant enterocin A (rEntA), purified by gel filtration chromatography, showed very strong activity against Listeria ivanovii ATCC 19119 with a low MIC of 20 ng/ml. In addition, the rEntA killed over 99% of tested L. ivanovii ATCC19119 within 4 h when exposed to 4?×?MIC (80 ng/ml). Moreover, it showed high stability under a wide pH range (2¿10) and maintained full activity after 1 h of treatment at 80°C within a pH range of 2¿8. Its antimicrobial activity was enhanced at 25 and 50 mM NaCl, while 100¿400 mM NaCl had little effect on the bactericidal ability of rEntA.

Conclusion

The EntA was successfully expressed in P. pastoris, and this feasible system could pave the pre-industrial technological path of rEntA as a competent candidate as an anti-Listeria agent. Furthermore, it showed high stability under wide ranges of conditions, which could be potential as the new candidate of anti-Listeria agent.

【 授权许可】

   
2014 Hu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150325025012652.pdf 2908KB PDF download
Figure 5. 19KB Image download
Figure 4. 71KB Image download
Figure 3. 48KB Image download
Figure 2. 85KB Image download
Figure 1. 51KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Lohans CT, Vederas JC: Development of Class IIa bacteriocins as therapeutic agents. Int J Microbiol 2012, 2012:1-13.
  • [2]Cotter PD, Hill C, Ross RP: Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005, 3:777-788.
  • [3]Ennahar S, Deschamps N: Anti-Listeria effect of enterocin A, produced by cheese-isolated Enterococcus faecium EFM01, relative to other bacteriocins from lactic acid bacteria. J Appl Microbiol 2000, 88:449-457.
  • [4]Cotter PD, Ross RP, Hill C: Bacteriocins-a viable alternative to antibiotics? Nat Rev Microbiol 2012, 11:95-105.
  • [5]Blay GL, Lacroix C, Zihler A, Fliss I: In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacterial. Lett Appl Microbiol 2007, 45:252-257.
  • [6]Engelbrecht F, Domínguez-Bernal G, Hess J, Dickneite C, Greiffenberg L, Lampidis R, Raffelsbauer D, Daniels JJ, Kreft J, Kaufmann SH: A novel PrfA-regulated chromosomal locus, which is specific for Listeria ivanovii, encodes two small, secreted internalins and contributes to virulence in mice. Mol Microbiol 1998, 30:405-417.
  • [7]Bodro M, Paterson DL: Listeriosis in patients receiving biologic therapies. Eur J Clin Microbiol Infect Dis 2013, 32:1225-1230.
  • [8]Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States¿major pathogensl. Emerg Infect Dis 2011, 17:7-15.
  • [9]Fallah AA, Saei-Dehkordi SS, Mahzounieh M: Occurrence and antibiotic resistance profiles of Listeria monocytogenes isolated from seafood products and market and processing environments in Iran. Food Control 2013, 34:630-636.
  • [10]Aymerich T, Holo H, Håvarstein LS, Hugas M, Garriga M, Nes IF: Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl Environ Microbiol 1996, 62:1676-1682.
  • [11]Herranz C, Casaus P, Mukhopadhyay S, Mart?nez J, Rodr?guez J, Nes I, Hernández P, Cintas L: Enterococcus faecium P21: a strain occurring naturally in dry-fermented sausages producing the class II bacteriocins enterocin A and enterocin B. Food Microbiol 2001, 18:115-131.
  • [12]Liu L, O¿Conner P, Cotter P, Hill C, Ross R: Controlling Listeria monocytogenes in cottage cheese through heterologous production of enterocin A by Lactococcus lactis. J Appl Microbiol 2008, 104:1059-1066.
  • [13]Rehaiem A, Martínez B, Manai M, Rodríguez A: Technological performance of the enterocin A producer Enterococcus faecium MMRA as a protective adjunct culture to enhance hygienic and sensory attributes of traditional fermented milk `Rayeb¿. Food Bioprocess Tech 2012, 5:2140-2150.
  • [14]Gutiérrez J, Criado R, Citti R, Martín M, Herranz C, Nes IF, Cintas LM, Hernández PE: Cloning, production and functional expression of enterocin P, a sec-dependent bacteriocin produced by Enterococcus faecium P13, in Escherichia coli. Int J Food Microbiol 2005, 103:239-250.
  • [15]Ingham A, Sproat K, Tizard M, Moore R: A versatile system for the expression of nonmodified bacteriocins in Escherichia coli. J Appl Microbiol 2005, 98:676-683.
  • [16]Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermúdez-Humarán LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE: Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 2005, 4:2. BioMed Central Full Text
  • [17]Gutiérrez J, Criado R, Martín M, Herranz C, Cintas LM, Hernández PE: Production of enterocin P, an antilisterial pediocin-like bacteriocin from Enterococcus faecium P13, in Pichia pastoris. Antimicrob Agents Chemother 2005, 49:3004-3008.
  • [18]Borrero J, Kunze G, Jiménez JJ, Böer E, Gútiez L, Herranz C, Cintas LM, Hernández PE: Cloning, production, and functional expression of the bacteriocin enterocin A, produced by Enterococcus faecium T136, by the Yeasts Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha, and Arxula adeninivorans. Appl Environ Microbiol 2012, 78:5956-5961.
  • [19]Li Y, Zhang B, Chen X, Cao Y: Improvement of Aspergillus sulphureus endo-?-1,4-xylanase expression in Pichia pastoris by codon optimization and analysis of the enzymic characterizationl. Appl Biochem Biotech 2010, 160:1321-1331.
  • [20]Hassan M, Kjos M, Nes I, Diep D, Lotfipour F: Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 2012, 113:723-736.
  • [21]Franz CM, Van Belkum MJ, Holzapfel WH, Abriouel H, Galvez A: Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol Rev 2007, 31:293-310.
  • [22]Martínez JM, Kok J, Sanders JW, Hernández PE: Heterologous coproduction of enterocin A and pediocin PA-1 by Lactococcus lactis: detection by specific peptide-directed antibodies. Appl Environ Microbiol 2000, 66:3543-3549.
  • [23]Klocke M, Mundt K, Idler F, Jung S, Backhausen JE: Heterologous expression of enterocin A, a bacteriocin from Enterococcus faecium, fused to a cellulose-binding domain in Escherichia coli results in a functional protein with inhibitory activity against Listeria. Appl Microbiol Biotechnol 2005, 67:532-538.
  • [24]Borrero J, Jiménez JJ, Gútiez L, Herranz C, Cintas LM, Hernández PE: Protein expression vector and secretion signal peptide optimization to drive the production, secretion, and functional expression of the bacteriocin enterocin A in lactic acid bacteria. J Biotechnol 2011, 156:76-86.
  • [25]Zorko M, Japelj B, Hafner-Bratkovic I, Jerala R: Expression, purification and structural studies of a short antimicrobial peptide. BBA-Biomembranes 2009, 1788:314-323.
  • [26]Kim J, Jang S, Yu B, Sung B, Cho J, Kim S: High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol 2008, 78:123-130.
  • [27]Sánchez J, Borrero J, Gómez-Sala B, Basanta A, Herranz C, Cintas L, Hernández PE: Cloning and heterologous production of hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris. Appl Environ Microbiol 2008, 74:2471-2479.
  • [28]Basanta A, Gómez-Sala B, Sánchez J, Diep DB, Herranz C, Hernández PE, Cintas LM: Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50. Appl Environ Microbio 2010, l76:3314-3324.
  • [29]Beaulieu L, Groleau D, Miguez CB, Jetté J-F, Aomari H, Subirade M: Production of pediocin PA-1 in the methylotrophic yeast Pichia pastoris reveals unexpected inhibition of its biological activity due to the presence of collagen-like material. Protein Expr Purif 2005, 43:111-125.
  • [30]Zhang J, Yang Y, Teng D, Tian Z, Wang S, Wang J: Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus. Protein Expr Purif 2011, 78:189-196.
  • [31]Zhang Y, Teng D, Mao R, Wang X, Xi D, Hu X, Wang J: High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus. Appl Microbiol Biotechnol 2014, 98:681-694.
  • [32]Mao R, Teng D, Wang X, Xi D, Zhang Y, Hu X, Yang Y, Wang J: Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus. Appl Microbiol Biotechnol 2013, 97:3991-4002.
  • [33]Richard C, Drider D, Elmorjani K, Marion D, Prévost H: Heterologous expression and purification of active Divercin V41, a Class IIa bacteriocin encoded by a synthetic gene in Escherichia coli. J Bacteriol 2004, 186:4276-4284.
  • [34]Casaus P, Nilsen T, Cintas LM, Nes IF, Hernández PE, Holo H: Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A. Microbiology 1997, 143:2287-2294.
  • [35]Kaur K, Andrew LC, Wishart DS, Vederas JC: Dynamic relationships among type IIa bacteriocins: temperature effects on antimicrobial activity and on structure of the C-terminal amphipathic ? helix as a receptor-binding region. Biochemistry 2004, 43:9009-9020.
  • [36]Jack RW, Wan J, Gordon J, Harmark K, Davidson BE, Hillier AJ, Wettenhall R, Hickey MW, Coventry MJ: Characterization of the chemical and antimicrobial properties of piscicolin 126, a bacteriocin produced by Carnobacterium piscicola JG126. Appl Environ Microbiol 1996, 62:2897-2903.
  • [37]Rehaiem A, Guerra NP, Belgacem ZB, Bernárdez PF, Castro LP, Manai M: Enhancement of enterocin A production by Enterococcus faecium MMRA and determination of its stability to temperature and pH. Biochem Eng J 2011, 56:94-106.
  • [38]Yamada O, Sakamoto K, Tominaga M, Nakayama T, Koseki T, Fujita A, Akita O: Cloning and heterologous expression of the antibiotic peptide (ABP) genes from Rhizopus oligosporus NBRC 8631. Biosci Biotechnol Biochem 2005, 69:477-482.
  • [39]Gänzle MG, Weber S, Hammes WP: Effect of ecological factors on the inhibitory spectrum and activity of bacteriocins. Int J Food Microbiol 1999, 46:207-217.
  • [40]Reenen V: Isolation, purification and partial characterization of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum. J Appl Microbiol 1998, 84:1131-1137.
  • [41]Rodriguez JM, Martinez MI, Kok J: Pediocin PA-1, a wide-spectrum bacteriocin from lactic acid bacteria. Crit Rev Food Sci Nutr 2002, 42:91-121.
  • [42]Bai X, Teng D, Tian Z, Zhu Y, Yang Y, Wang J: Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus. BioMetals 2010, 23:431-439.
  • [43]Schägger H: Tricine¿SDS-PAGE. Nat Protoc 2006, 1:16-22.
  • [44]Iwatani S, Zendo T, Yoneyama F, Nakayama J, Sonomoto K: Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14. Biosci Biotechnol Biochem 2007, 71:1984-1992.
  文献评价指标  
  下载次数:18次 浏览次数:15次